Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19336929rdf:typepubmed:Citationlld:pubmed
pubmed-article:19336929lifeskim:mentionsumls-concept:C0330090lld:lifeskim
pubmed-article:19336929lifeskim:mentionsumls-concept:C1673848lld:lifeskim
pubmed-article:19336929lifeskim:mentionsumls-concept:C0007935lld:lifeskim
pubmed-article:19336929lifeskim:mentionsumls-concept:C0017977lld:lifeskim
pubmed-article:19336929lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:19336929lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:19336929lifeskim:mentionsumls-concept:C0060425lld:lifeskim
pubmed-article:19336929pubmed:issue4lld:pubmed
pubmed-article:19336929pubmed:dateCreated2009-4-1lld:pubmed
pubmed-article:19336929pubmed:abstractTextThe methanolic extract from the flowers of Helichrysum arenarium L. MOENCH was found to show inhibitory effect on tumor necrosis factor-alpha (TNF-alpha, 1 ng/ml)-induced cytotoxicity in L929 cells. From the methanolic extract, 50 constituents including four new flavanone and chalcone glycosides named arenariumosides I (1), II (2), III (3), and IV (4) were isolated. The stereostructures of 1-4 were elucidated on the basis of chemical and physicochemical evidence. Among the constituents, naringenin 7-O-beta-D-glucopyranoside (7), apigenin 7-O-beta-D-glucopyranoside (14), apigenin 7-O-gentiobioside (16), and apigenin 7,4'-di-O-beta-D-glucopyranoside (17) significantly inhibited TNF-alpha-induced cytotoxicity in L929 cells at 30 microM.lld:pubmed
pubmed-article:19336929pubmed:languageenglld:pubmed
pubmed-article:19336929pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19336929pubmed:citationSubsetIMlld:pubmed
pubmed-article:19336929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19336929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19336929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19336929pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19336929pubmed:statusMEDLINElld:pubmed
pubmed-article:19336929pubmed:monthAprlld:pubmed
pubmed-article:19336929pubmed:issn0009-2363lld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:MatsudaHisash...lld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:YoshikawaMasa...lld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:MorikawaToshi...lld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:NinomiyaKiyof...lld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:MuraokaOsamuOlld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:WuLi-JunLJlld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:NakamuraSeiko...lld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:WangLi-BoLBlld:pubmed
pubmed-article:19336929pubmed:authorpubmed-author:YokoyamaEriElld:pubmed
pubmed-article:19336929pubmed:issnTypePrintlld:pubmed
pubmed-article:19336929pubmed:volume57lld:pubmed
pubmed-article:19336929pubmed:ownerNLMlld:pubmed
pubmed-article:19336929pubmed:authorsCompleteYlld:pubmed
pubmed-article:19336929pubmed:pagination361-7lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:meshHeadingpubmed-meshheading:19336929...lld:pubmed
pubmed-article:19336929pubmed:year2009lld:pubmed
pubmed-article:19336929pubmed:articleTitleMedicinal flowers. XXVII. New flavanone and chalcone glycosides, arenariumosides I, II, III, and IV, and tumor necrosis factor-alpha inhibitors from everlasting, flowers of Helichrysum arenarium.lld:pubmed
pubmed-article:19336929pubmed:affiliationPharmaceutical Research and Technology Institute, Kinki University, Osaka, Japan.lld:pubmed
pubmed-article:19336929pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19336929pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed